Postema, Pieter G; Neville, Jon; de Jong, Jonas S S G et al. (2013) Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics. Europace 15:1042-9
|
Malone, Daniel C; Liberman, Joshua N; Sun, Diana (2013) Effect of an educational outreach program on prescribing potential drug-drug interactions. J Manag Care Pharm 19:549-57
|
Malone, Daniel C; Saverno, Kimberly R (2012) Evaluation of a wireless handheld medication management device in the prevention of drug-drug interactions in a Medicaid population. J Manag Care Pharm 18:33-45
|
Higgins, Lisa; Brown, Mary; Murphy, John E et al. (2011) Community pharmacy and pharmacist staff call center: assessment of medication safety and effectiveness. J Am Pharm Assoc (2003) 51:82-9
|
Ko, Yu; Malone, Daniel C; Skrepnek, Grant H et al. (2008) Prescribers'knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Saf 31:525-36
|
Ko, Yu; Malone, Daniel C; D'Agostino, Jerome V et al. (2008) Potential determinants of prescribers'drug-drug interaction knowledge. Res Social Adm Pharm 4:355-66
|
Katchman, Alexander N; Koerner, John; Tosaka, Toshimasa et al. (2006) Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J Pharmacol Exp Ther 316:1098-106
|
Kornick, Craig A; Kilborn, Michael J; Santiago-Palma, Juan et al. (2003) QTc interval prolongation associated with intravenous methadone. Pain 105:499-506
|
Law, Amy W; Reed, Shelby D; Sundy, John S et al. (2003) Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol 111:296-300
|
Yasuda, Sally Usdin; Zannikos, Peter; Young, Andrea E et al. (2002) The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine. Br J Clin Pharmacol 53:519-25
|
Showing the most recent 10 out of 13 publications